Page 89 - Read Online

Page 6 of 7 Di Costanzo et al. Hepatoma Res 2018;4:53 I http://dx.doi.org/10.20517/2394-5079.2018.56

Koike K. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroent 2012;107:569-77.
26 Haemmerich D, Tungjitkusolmun S, Staelin ST, Lee FT, Mahvi DM, Webster JG. Finite-element analysis of hepatic multiple probe radio-
frequency ablation. IEEE Trans Biomed Eng 2002;49:836-42.
27 Seror O, N’Kontchou G, Ibraheem M, Ajavon Y, Barrucand C, Ganne N, Coderc E, Trinchet JC, Beaugrand M, Sellier N. Large (>or=5.0-
cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes–initial experience in 26 patients. Radiology 2008;248:288-
96.
28 Cartier V, Boursier J, Lebigot J, Oberti F, Fouchard-Hubert I, Aubé C. Radiofrequency ablation of hepatocellular carcinoma: Mono or
multipolar? J Gastroenterol Hepatol 2016;31:654-60.
29 Miao Y, Ni Y, Yu J, Zhang H, Baert A, Marchal G. An ex vivo study on radiofrequency tissue ablation: increased lesion size by using an
“expandable-wet” electrode. Eur Radiol 2001;11:1841-47.
30 Shibata T, Shibata T, Maetani Y, Isoda H, Hiraoka, M. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison
of internally cooled electrode and expandable electrode. Radiology 2006;238:346-53.
31 Brace CL, Sampson LA, Hinshaw JL, Sandhu N, Lee FT Jr. Radiofrequency ablation: simultaneous application of multiple electrodes via
switching creates larger, more confluent ablations than sequential application in a large animal model. J Vasc Interv Radiol 2009;20:118-24.
32 Haemmerich D, Lee FT Jr. Multiple applicator approaches for radiofrequency and microwave ablation. Int J Hyperthermia 2005;21:93-106.
33 Zhang YJ, Liang HH, Chen MS, Guo RP, Li JQ, Zheng Y, Zhang YQ, Lau WY. Hepatocellular carcinoma treated with radiofrequency
ablation with or without ethanol injection: a prospective randomized trial. Radiology 2007;244:599-607.
34 Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, Yi CH. Chemoembolization combined with radiofrequency ablation for patients
with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 2008;299:1669-77.
35 Qi X, Zhao Y, Li H, Guo X, Han G. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.
Oncotarget 2016;7:34703-51.
36 Yang P, Liang M, Zhang Y, Shen B. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
Advances in Therapy 2008;25:787-94.
37 Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for
hepatocellular carcinoma. World J Gastroenterol 2013;19:3872-82.
38 Fukuda H, Numata K, Moriya S, Shimoyama Y, Ishii T, Nozaki A, Kondo M, Morimoto M, Maeda S, Sakamaki K, Morita S, Tanaka K.
Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation—propensity score matching analysis.
Radiology 2014;272:598-604.
39 Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial
chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012;262:689-700.
40 Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Small hepatocellular carcinoma: is radiofrequency ablation combined
with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 2009;252:905-13.
41 Wang X, Hu Y, Ren M, Lu X, Lu G, He S. Efficacy and safety of radiofrequency ablation combined with transcatheter arterial
chemoembolization for hepatocellular carcinomas compared with radiofrequency ablation alone: a time-to-event meta-analysis. Korean J
Radiol 2016;17:93-102.
42 Feng X, Xu R, Du X, Dou K, Qin X, Xu J, Jia W, Wang Z, Zhao H, Yang S, Guo C, Liu T, Ma K. Combination therapy with sorafenib
and radiofrequency ablation for BCLC stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study. Am J Gastroenterol
2014;109:1891-9.
43 Li Y, Zheng YB, Zhao W, Liu B, Hu BS, He X, Huang JW, Lu LG. Sorafenib in combination with transarterial chemoembolization and
radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma. Med Oncol 2013;30:730.
44 Zhu K, Huang J, Lai L, Huang W, Cai M, Zhou J, Guo Y, Chen J. Medium or large hepatocellular carcinoma: sorafenib combined with
transarterial chemoembolization and radiofrequency ablation. Radiology 2018;288:300-7.
45 Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-
frequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441-51.
46 Ding J, Jing X, Liu J, Wang Y, Wang F, Du Z. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and
microwave ablative techniques. Clin Radiol 2013;66:608-15.
47 Lee MW, Raman SS, Asvadi NH, Siripongsakun S, Hicks RM, Chen J, Worakitsitisatorn A, McWilliams J, Tong MJ, Finn RS, Agopian VG,
Busuttil RW, Lu DSK. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: a 10-year intention-
to-treat analysis. Hepatology 2017;65:1979-90.
48 Giorgio A, Merola MG, Montesarchio L, Merola F, Gatti P, Coppola C, Giorgio V, Calisti G. Percutaneous radiofrequency ablation of
hepatocellular carcinoma in cirrhosis: analysis of complications in a single centre over 20 years. Br J Radiol 2017;90:20160804.
49 Livraghi T, Meloni F, Solbiati L, Zanus G, Collaborative Italian Group using AMICA system. Complications of microwave ablation for liver
tumors: Results of a multicenter study. Cardiovasc Intervent Radiol 2012;35:868-74.
50 Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology 2012;262:43-58.
51 Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee Jr FT. Radiofrequency versus microwave ablation in a hepatic porcine model.
Radiology 2005;236:132-9.
52 Li X, Zhang L, Fan W, Zhao M, Wang L, Tang T, Jiang H, Zhang J, Liu Y. Comparison of microwave ablation and multipolar
radiofrequency ablation, both using a pair of internally cooled interstitial applicators: results in ex vivo porcine livers. Int J Hyperthermia
2011;27:240-8.
53 Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular
carcinoma: A systematic review and meta-analysis. Int J Hyperthermia 2016;32:339-44.
54 Chinnaratha MA, Chuang MYA, Fraser RJ, Woodman RJ, Wigg AJ. Percutaneous thermal ablation for primary hepatocellular carcinoma: a
systematic review and meta-analysis. J Gastroenterol Hepatol 2016;31:294-301.
55 Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, Xu ZF, Liu GJ, Zheng YL. Percutaneous microwave and radiofrequency ablation for